Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

Severity of airflow limitation, co-morbidities and management of chronic obstructive pulmonary disease patients acutely admitted to hospital.

Au LH, Chan HS.

Hong Kong Med J. 2013 Dec;19(6):498-503. doi: 10.12809/hkmj133909. Epub 2013 Jun 20.

2.

Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study.

Wurst KE, Shukla A, Muellerova H, Davis KJ.

COPD. 2014 Sep;11(5):521-30. doi: 10.3109/15412555.2014.922064. Epub 2014 Jun 19.

PMID:
24945236
3.

Indacaterol therapy in moderate-to-severe chronic obstructive pulmonary disease: findings from a single-center primary care cohort.

Singh MP.

Int J Chron Obstruct Pulmon Dis. 2013;8:613-9. doi: 10.2147/COPD.S53707. Epub 2013 Dec 9.

4.

Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids.

Asche CV, Leader S, Plauschinat C, Raparla S, Yan M, Ye X, Young D.

Int J Chron Obstruct Pulmon Dis. 2012;7:201-9. doi: 10.2147/COPD.S25805. Epub 2012 Mar 15.

5.

Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society.

Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, van der Molen T, Marciniuk DD, Denberg T, Schünemann H, Wedzicha W, MacDonald R, Shekelle P; American College of Physicians; American College of Chest Physicians; American Thoracic Society; European Respiratory Society.

Ann Intern Med. 2011 Aug 2;155(3):179-91. doi: 10.7326/0003-4819-155-3-201108020-00008.

PMID:
21810710
6.

Treatment of patients with chronic obstructive pulmonary disease as practised in a defined Hong Kong community: a cross-sectional pilot survey.

Yu WC, Tai EL, Fu SN, Kwong KC, Yeung YC, Chang Y, Yiu YK, Tam CM.

Hong Kong Med J. 2011 Aug;17(4):306-14.

7.

Variation in adherence with Global Initiative for Chronic Obstructive Lung Disease (GOLD) drug therapy guidelines: a retrospective actuarial claims data analysis.

Fitch K, Iwasaki K, Pyenson B, Plauschinat C, Zhang J.

Curr Med Res Opin. 2011 Jul;27(7):1425-9. doi: 10.1185/03007995.2011.583230. Epub 2011 May 23.

PMID:
21599554
8.

Spirometry is underused in the diagnosis and monitoring of patients with chronic obstructive pulmonary disease (COPD).

Yu WC, Fu SN, Tai EL, Yeung YC, Kwong KC, Chang Y, Tam CM, Yiu YK.

Int J Chron Obstruct Pulmon Dis. 2013;8:389-95. doi: 10.2147/COPD.S48659. Epub 2013 Aug 26.

9.
10.

How far is real life from COPD therapy guidelines? An Italian observational study.

Corrado A, Rossi A.

Respir Med. 2012 Jul;106(7):989-97. doi: 10.1016/j.rmed.2012.03.008. Epub 2012 Apr 5.

11.

Perseverant, non-indicated treatment of obese patients for obstructive lung disease.

Fortis S, Kittah J, De Aguirre M, Plataki M, Wolff A, Amoateng-Adjepong Y, Manthous CA.

BMC Pulm Med. 2013 Nov 22;13:68. doi: 10.1186/1471-2466-13-68.

12.

Guideline adherence in management of stable chronic obstructive pulmonary disease.

Sharif R, Cuevas CR, Wang Y, Arora M, Sharma G.

Respir Med. 2013 Jul;107(7):1046-52. doi: 10.1016/j.rmed.2013.04.001. Epub 2013 Apr 30.

13.

Prevalence of airflow limitation on medical check-up in Japanese subjects.

Omori H, Nonami Y, Mihara S, Marubayashi T, Morimoto Y, Aizawa H.

J UOEH. 2007 Sep 1;29(3):209-19.

PMID:
17900001
14.

[Diagnosis and management of chronic obstructive pulmonary disease].

Sato N, Kanazawa M.

Kyobu Geka. 2007 Aug;60(9):841-8. Japanese.

PMID:
17703625
15.

Accuracy of diagnostic registers and management of chronic obstructive pulmonary disease: the Devon primary care audit.

Jones RC, Dickson-Spillmann M, Mather MJ, Marks D, Shackell BS.

Respir Res. 2008 Aug 18;9:62. doi: 10.1186/1465-9921-9-62.

16.

Long-acting bronchodilator use after hospitalization for COPD: an observational study of health insurance claims data.

Baker CL, Zou KH, Su J.

Int J Chron Obstruct Pulmon Dis. 2014 May 3;9:431-9. doi: 10.2147/COPD.S59322. eCollection 2014.

17.

Spirometry for patients in hospital and one month after admission with an acute exacerbation of COPD.

Rea H, Kenealy T, Adair J, Robinson E, Sheridan N.

Int J Chron Obstruct Pulmon Dis. 2011;6:527-32. doi: 10.2147/COPD.S24133. Epub 2011 Oct 14.

18.

Impact of adherence to the GOLD guidelines on symptom prevalence, lung function decline and exacerbation rate in the Swiss COPD cohort.

Jochmann A, Scherr A, Jochmann DC, Miedinger D, Török SS, Chhajed PN, Tamm M, Leuppi JD.

Swiss Med Wkly. 2012 Apr 5;142:w13567. doi: 10.4414/smw.2012.13567.

19.

Diagnosis and management of chronic obstructive pulmonary disease (COPD) in a primary care clinic.

Chavez PC, Shokar NK.

COPD. 2009 Dec;6(6):446-51. doi: 10.3109/15412550903341455.

PMID:
19938968
Items per page

Supplemental Content

Write to the Help Desk